REZOLUTE, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
REZOLUTE, INC. (RZLT) had Lessee, Operating Lease, Liability, to be Paid, Year One of $750.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-09-24
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $750.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $750.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $750.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $750.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $750.00K 10-K · filed 2026-09-24 |
| 2026-03-31 | $750.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $750.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $750.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $770.00K 10-K · filed 2025-09-17 |
| 2025-03-31 | $770.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $770.00K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $770.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $748.00K 10-K · filed 2024-09-19 |
| 2024-03-31 | $748.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $748.00K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $627.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $689.00K 10-K · filed 2023-09-14 |
| 2023-03-31 | $689.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $689.00K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $79.00K 10-Q · filed 2022-11-09 |
| 2022-03-31 | $117.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $117.00K 10-Q · filed 2022-02-09 |
| 2021-09-30 | $117.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $283.00K 10-K · filed 2021-09-15 |
| 2021-03-31 | $283.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $283.00K 10-Q · filed 2021-02-10 |
| 2020-09-30 | $170.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $272.00K 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |